Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

BUY
$44.33 - $57.82 $2.77 Million - $3.61 Million
62,500 Added 194.7%
94,600 $5.47 Million
Q4 2021

Feb 15, 2022

SELL
$40.27 - $56.99 $833,589 - $1.18 Million
-20,700 Reduced 39.2%
32,100 $1.43 Million
Q3 2021

Nov 16, 2021

BUY
$47.43 - $84.23 $2.3 Million - $4.09 Million
48,500 Added 1127.91%
52,800 $2.54 Million
Q2 2021

Aug 16, 2021

SELL
$73.06 - $97.7 $204,568 - $273,560
-2,800 Reduced 39.44%
4,300 $365,000
Q1 2021

May 18, 2021

BUY
$70.43 - $97.42 $218,333 - $302,002
3,100 Added 77.5%
7,100 $596,000
Q4 2020

Feb 17, 2021

BUY
$48.9 - $75.26 $195,600 - $301,040
4,000 New
4,000 $301,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.81B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.